MedTrace Logo

Solitaire FR Thrombectomy for Acute Revascularisation

NCT01327989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 202

Last updated 2017-01-27

Study results available
· View outcomes & findings →

Summary

The objective of this study was to obtain prospective clinical data on the safety and efficacy of the Solitaire™ FR device for patients diagnosed with acute ischemic stroke.

Conditions

  • Stroke, Acute

Interventions

DEVICE

Solitaire™ FR device

Mechanical Thrombectomy

Sponsors & Collaborators

  • ev3 International

    collaborator INDUSTRY

  • Medtronic Neurovascular Clinical Affairs

    lead INDUSTRY

Principal Investigators

  • Vitor Mendes Pereira, Dr · HUG Geneva

  • Jan Gralla, Dr · Inselspital University Hospital of Bern

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-10-31
Completion
2013-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01327989 on ClinicalTrials.gov